Pharmacy

Your Article Summary

See Latest Articles

BL-1020, a novel antipsychotic candidate with GABA-enhancing effects: D2 receptor occupancy study in humans
European Neuropsychopharmacology, 09/04/09

Appel L et al. – Pharmacokinetic–pharmacodynamic analysis predicted that oral once daily administration of 32 mg BL–1020 would result in D2 ROs ranging from 52 to 66% at a steady state.

Today in Major Studies...keeping you current

Receive free subspecialty "5-minute updates" via email

Carboplatin-Pemetrexed Adjuvant Chemotherapy in Resected Non-small Cell Lung Cancer (NSCLC): A Phase II Study
Anticancer Research, 11/16/09

A simple cost-effective high performance liquid chromatographic assay of sulphadoxine in whole blood spotted on filter paper for field studies
Malaria Journal, 10/27/09

Psychopharmacology Curriculum Field Test
Academic Psychiatry, 10/16/09

See All of Major Studies

Today in Neuro/Psych pharmacology...keeping you current

Receive free subspecialty "5-minute updates" via email

Cardiometabolic Risk of Second-Generation Antipsychotic Medications During First-Time Use in Children and Adolescents
JAMA, 10/29/09

Escitalopram and Venlafaxine for the Prophylaxis of Migraine Headache Without Mood Disorders
Clinical Neuropharmacology, 10/02/09

Outcome of intracerebral haemorrhage patients pre-treated with statins
European Journal of Neurology, 11/17/09

See All of Neuro/Psych pharmacology

Today in Pharmacokinetics...keeping you current

Receive free subspecialty "5-minute updates" via email

U-500 Regular Insulin: Clinical Experience and Pharmacokinetics in Obese, Severely Insulin Resistant Type 2 Diabetic Patients
Diabetes Care, 11/16/09

The role of ceramide in major depressive disorder
European Archives of Psychiatry and Clinical Neuroscience, 11/12/09

Randomized Trial and Pharmacokinetic Study of Pegfilgrastim versus Filgrastim after Dose-Intensive Chemotherapy in Young Adults and Children with Sarcomas
Clinical Cancer Research, 11/20/09

See All of Pharmacokinetics